Advances in Vaccination against Tick-Borne Pathogens

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 128

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland
Interests: central nervous system infections; tick-borne diseases; parasitic diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland
Interests: tick-borne diseases; meningitis; encephalitis; respiratory pathogens
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Ticks are known to transmit a variety of microorganisms to both animals and humans. Among the most notable are Borrelia bacteria, the tick-borne encephalitis virus, and the Babesia parasite, which have increasingly drawn public attention. The diseases caused by these pathogens are expanding into new regions worldwide.

Currently, effective and safe vaccines are available for tick-borne encephalitis (TBE), offering protection against this potentially severe disease. However, Lyme disease, caused by Borrelia bacteria, still lacks a registered vaccine, although promising developments are underway. The absence of a Lyme disease vaccine underscores the urgent need for ongoing research and innovation in vaccine development to better protect public health.

Recent research has provided valuable insights into various aspects of tick-borne disease prevention. Studies have explored the progress in Lyme disease vaccine development, examined breakthrough cases in TBE vaccination, and investigated other related topics.

This Special Issue is dedicated to preventing diseases transmitted by tick bites, emphasizing the importance of vaccine development and public health strategies. We encourage submissions on topics such as the molecular aspects of vaccine development, the immunogenicity and efficacy of vaccines, immune responses, coverage, and the public’s perception and acceptance of these vaccines. Contributions that address the challenges and opportunities in preventing tick-borne diseases are particularly welcome, as they can help shape future research and public health policies.

We look forward to receiving your contributions.

Prof. Dr. Artur Sulik
Dr. Kacper Toczylowski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tick-borne diseases
  • tick-borne encephalitis
  • Lyme disease
  • Lyme disease vaccine
  • ticks
  • immunization

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop